nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—epilepsy syndrome	0.228	1	CbGaD
Riluzole—SCN5A—Oxcarbazepine—epilepsy syndrome	0.0731	0.154	CbGbCtD
Riluzole—SCN5A—Fosphenytoin—epilepsy syndrome	0.0639	0.135	CbGbCtD
Riluzole—SCN5A—Lamotrigine—epilepsy syndrome	0.0533	0.112	CbGbCtD
Riluzole—SCN5A—Rufinamide—epilepsy syndrome	0.0471	0.0993	CbGbCtD
Riluzole—SCN5A—Carbamazepine—epilepsy syndrome	0.0459	0.0967	CbGbCtD
Riluzole—SCN5A—Phenytoin—epilepsy syndrome	0.0412	0.0868	CbGbCtD
Riluzole—SCN5A—Zonisamide—epilepsy syndrome	0.034	0.0715	CbGbCtD
Riluzole—SCN5A—Topiramate—epilepsy syndrome	0.0248	0.0521	CbGbCtD
Riluzole—CYP1A1—Propofol—epilepsy syndrome	0.0199	0.042	CbGbCtD
Riluzole—CYP1A1—Phenobarbital—epilepsy syndrome	0.0191	0.0401	CbGbCtD
Riluzole—CYP1A2—Carbamazepine—epilepsy syndrome	0.0106	0.0224	CbGbCtD
Riluzole—CYP1A2—Primidone—epilepsy syndrome	0.00994	0.0209	CbGbCtD
Riluzole—CYP1A2—Propofol—epilepsy syndrome	0.00891	0.0188	CbGbCtD
Riluzole—CYP1A2—Phenobarbital—epilepsy syndrome	0.00851	0.0179	CbGbCtD
Riluzole—CYP1A2—Diazepam—epilepsy syndrome	0.00807	0.017	CbGbCtD
Riluzole—CYP1A2—Valproic Acid—epilepsy syndrome	0.00636	0.0134	CbGbCtD
Riluzole—SLC7A11—tongue—epilepsy syndrome	0.00248	0.209	CbGeAlD
Riluzole—SLC7A11—forebrain—epilepsy syndrome	0.00105	0.0885	CbGeAlD
Riluzole—SLC7A11—telencephalon—epilepsy syndrome	0.000967	0.0814	CbGeAlD
Riluzole—SLC7A11—midbrain—epilepsy syndrome	0.000694	0.0585	CbGeAlD
Riluzole—SLC7A11—spinal cord—epilepsy syndrome	0.000677	0.057	CbGeAlD
Riluzole—SLC7A11—head—epilepsy syndrome	0.000602	0.0507	CbGeAlD
Riluzole—SLC7A11—nervous system—epilepsy syndrome	0.000571	0.0481	CbGeAlD
Riluzole—SLC7A11—central nervous system—epilepsy syndrome	0.00055	0.0463	CbGeAlD
Riluzole—SLC7A11—cerebellum—epilepsy syndrome	0.000537	0.0452	CbGeAlD
Riluzole—SLC7A11—brain—epilepsy syndrome	0.000436	0.0367	CbGeAlD
Riluzole—SCN5A—head—epilepsy syndrome	0.000362	0.0305	CbGeAlD
Riluzole—SCN5A—nervous system—epilepsy syndrome	0.000344	0.0289	CbGeAlD
Riluzole—SCN5A—central nervous system—epilepsy syndrome	0.000331	0.0278	CbGeAlD
Riluzole—ABCG2—telencephalon—epilepsy syndrome	0.000318	0.0268	CbGeAlD
Riluzole—SCN5A—brain—epilepsy syndrome	0.000263	0.0221	CbGeAlD
Riluzole—ABCG2—medulla oblongata—epilepsy syndrome	0.00025	0.0211	CbGeAlD
Riluzole—ABCG2—midbrain—epilepsy syndrome	0.000229	0.0192	CbGeAlD
Riluzole—ABCG2—spinal cord—epilepsy syndrome	0.000223	0.0188	CbGeAlD
Riluzole—CYP1A1—head—epilepsy syndrome	0.000188	0.0158	CbGeAlD
Riluzole—CYP1A1—nervous system—epilepsy syndrome	0.000178	0.015	CbGeAlD
Riluzole—ABCG2—cerebellum—epilepsy syndrome	0.000177	0.0149	CbGeAlD
Riluzole—CYP1A1—central nervous system—epilepsy syndrome	0.000172	0.0145	CbGeAlD
Riluzole—ABCG2—brain—epilepsy syndrome	0.000144	0.0121	CbGeAlD
Riluzole—CYP1A1—brain—epilepsy syndrome	0.000136	0.0115	CbGeAlD
Riluzole—SCN5A—Developmental Biology—CDC42—epilepsy syndrome	2.83e-05	0.000421	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.82e-05	0.000418	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.81e-05	0.000417	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GAMT—epilepsy syndrome	2.8e-05	0.000416	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—EPM2A—epilepsy syndrome	2.8e-05	0.000416	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NHLRC1—epilepsy syndrome	2.8e-05	0.000416	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PNPO—epilepsy syndrome	2.8e-05	0.000416	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6ST—epilepsy syndrome	2.79e-05	0.000415	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ALB—epilepsy syndrome	2.75e-05	0.000409	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CA13—epilepsy syndrome	2.73e-05	0.000406	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	2.71e-05	0.000403	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	2.71e-05	0.000403	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.71e-05	0.000403	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.71e-05	0.000403	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	2.64e-05	0.000392	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CA4—epilepsy syndrome	2.6e-05	0.000386	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—QDPR—epilepsy syndrome	2.6e-05	0.000386	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.6e-05	0.000386	CbGpPWpGaD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.6e-05	0.000386	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HES1—epilepsy syndrome	2.59e-05	0.000386	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	2.56e-05	0.000381	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	2.55e-05	0.000378	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	2.53e-05	0.000376	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—FYN—epilepsy syndrome	2.52e-05	0.000375	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.51e-05	0.000373	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MEF2C—epilepsy syndrome	2.51e-05	0.000373	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.5e-05	0.000371	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.47e-05	0.000367	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—COX3—epilepsy syndrome	2.44e-05	0.000363	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.42e-05	0.000359	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.4e-05	0.000356	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	2.38e-05	0.000354	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.38e-05	0.000354	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLCO1A2—epilepsy syndrome	2.32e-05	0.000344	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CACNA2D2—epilepsy syndrome	2.32e-05	0.000344	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PFKL—epilepsy syndrome	2.32e-05	0.000344	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—KCNB1—epilepsy syndrome	2.32e-05	0.000344	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC6A8—epilepsy syndrome	2.32e-05	0.000344	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	2.31e-05	0.000343	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	2.28e-05	0.000339	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.25e-05	0.000335	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.25e-05	0.000334	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	2.24e-05	0.000332	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.2e-05	0.000327	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.15e-05	0.00032	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—UPB1—epilepsy syndrome	2.12e-05	0.000315	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ATIC—epilepsy syndrome	2.12e-05	0.000315	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NEU1—epilepsy syndrome	2.12e-05	0.000315	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.11e-05	0.000313	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KDR—epilepsy syndrome	2.08e-05	0.000309	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FAR1—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ADK—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—L2HGDH—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CERS1—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GLUD1—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PDXK—epilepsy syndrome	2.07e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.05e-05	0.000305	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HSD17B4—epilepsy syndrome	2.04e-05	0.000303	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.02e-05	0.0003	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—epilepsy syndrome	2.01e-05	0.000299	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6ST—epilepsy syndrome	1.99e-05	0.000296	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.98e-05	0.000294	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GBE1—epilepsy syndrome	1.97e-05	0.000293	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPP1R3C—epilepsy syndrome	1.97e-05	0.000293	CbGpPWpGaD
Riluzole—Diarrhoea—Clonazepam—epilepsy syndrome	1.95e-05	8.98e-05	CcSEcCtD
Riluzole—Anaemia—Gabapentin—epilepsy syndrome	1.95e-05	8.97e-05	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—SRC—epilepsy syndrome	1.95e-05	0.000289	CbGpPWpGaD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.95e-05	8.95e-05	CcSEcCtD
Riluzole—Hypotension—Valproic Acid—epilepsy syndrome	1.94e-05	8.93e-05	CcSEcCtD
Riluzole—Asthenia—Carbamazepine—epilepsy syndrome	1.94e-05	8.92e-05	CcSEcCtD
Riluzole—Agitation—Gabapentin—epilepsy syndrome	1.94e-05	8.92e-05	CcSEcCtD
Riluzole—Diarrhoea—Phenytoin—epilepsy syndrome	1.94e-05	8.92e-05	CcSEcCtD
Riluzole—Discomfort—Pregabalin—epilepsy syndrome	1.94e-05	8.9e-05	CcSEcCtD
Riluzole—Nausea—Fosphenytoin—epilepsy syndrome	1.93e-05	8.89e-05	CcSEcCtD
Riluzole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.93e-05	8.87e-05	CcSEcCtD
Riluzole—Erythema multiforme—Topiramate—epilepsy syndrome	1.93e-05	8.87e-05	CcSEcCtD
Riluzole—Angioedema—Gabapentin—epilepsy syndrome	1.93e-05	8.87e-05	CcSEcCtD
Riluzole—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.93e-05	8.86e-05	CcSEcCtD
Riluzole—Vomiting—Felbamate—epilepsy syndrome	1.92e-05	8.84e-05	CcSEcCtD
Riluzole—Dry mouth—Pregabalin—epilepsy syndrome	1.92e-05	8.81e-05	CcSEcCtD
Riluzole—Pruritus—Carbamazepine—epilepsy syndrome	1.91e-05	8.8e-05	CcSEcCtD
Riluzole—Rash—Felbamate—epilepsy syndrome	1.91e-05	8.77e-05	CcSEcCtD
Riluzole—Eye disorder—Topiramate—epilepsy syndrome	1.91e-05	8.76e-05	CcSEcCtD
Riluzole—Dermatitis—Felbamate—epilepsy syndrome	1.91e-05	8.76e-05	CcSEcCtD
Riluzole—Malaise—Gabapentin—epilepsy syndrome	1.9e-05	8.75e-05	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—VEGFA—epilepsy syndrome	1.9e-05	0.000282	CbGpPWpGaD
Riluzole—Vertigo—Gabapentin—epilepsy syndrome	1.9e-05	8.72e-05	CcSEcCtD
Riluzole—Headache—Felbamate—epilepsy syndrome	1.9e-05	8.71e-05	CcSEcCtD
Riluzole—Confusional state—Pregabalin—epilepsy syndrome	1.89e-05	8.71e-05	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.89e-05	8.7e-05	CcSEcCtD
Riluzole—Cardiac disorder—Topiramate—epilepsy syndrome	1.89e-05	8.7e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—EPM2A—epilepsy syndrome	1.89e-05	0.000281	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PNPO—epilepsy syndrome	1.89e-05	0.000281	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NHLRC1—epilepsy syndrome	1.89e-05	0.000281	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GAMT—epilepsy syndrome	1.89e-05	0.000281	CbGpPWpGaD
Riluzole—Syncope—Gabapentin—epilepsy syndrome	1.89e-05	8.7e-05	CcSEcCtD
Riluzole—Leukopenia—Gabapentin—epilepsy syndrome	1.89e-05	8.69e-05	CcSEcCtD
Riluzole—Dizziness—Clonazepam—epilepsy syndrome	1.89e-05	8.67e-05	CcSEcCtD
Riluzole—Nausea—Vigabatrin—epilepsy syndrome	1.89e-05	8.67e-05	CcSEcCtD
Riluzole—Vomiting—Zonisamide—epilepsy syndrome	1.88e-05	8.65e-05	CcSEcCtD
Riluzole—Insomnia—Valproic Acid—epilepsy syndrome	1.88e-05	8.64e-05	CcSEcCtD
Riluzole—Oedema—Pregabalin—epilepsy syndrome	1.88e-05	8.64e-05	CcSEcCtD
Riluzole—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.88e-05	8.64e-05	CcSEcCtD
Riluzole—Asthenia—Lamotrigine—epilepsy syndrome	1.88e-05	8.62e-05	CcSEcCtD
Riluzole—Dizziness—Phenytoin—epilepsy syndrome	1.87e-05	8.62e-05	CcSEcCtD
Riluzole—Rash—Zonisamide—epilepsy syndrome	1.87e-05	8.58e-05	CcSEcCtD
Riluzole—Infection—Pregabalin—epilepsy syndrome	1.87e-05	8.58e-05	CcSEcCtD
Riluzole—Paraesthesia—Valproic Acid—epilepsy syndrome	1.87e-05	8.58e-05	CcSEcCtD
Riluzole—Palpitations—Gabapentin—epilepsy syndrome	1.87e-05	8.57e-05	CcSEcCtD
Riluzole—Dermatitis—Zonisamide—epilepsy syndrome	1.87e-05	8.57e-05	CcSEcCtD
Riluzole—Dizziness—Oxcarbazepine—epilepsy syndrome	1.86e-05	8.57e-05	CcSEcCtD
Riluzole—Nausea—Diazepam—epilepsy syndrome	1.86e-05	8.53e-05	CcSEcCtD
Riluzole—Loss of consciousness—Gabapentin—epilepsy syndrome	1.86e-05	8.53e-05	CcSEcCtD
Riluzole—Headache—Zonisamide—epilepsy syndrome	1.86e-05	8.53e-05	CcSEcCtD
Riluzole—Dyspnoea—Valproic Acid—epilepsy syndrome	1.85e-05	8.52e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ASAH1—epilepsy syndrome	1.85e-05	0.000275	CbGpPWpGaD
Riluzole—Diarrhoea—Carbamazepine—epilepsy syndrome	1.85e-05	8.51e-05	CcSEcCtD
Riluzole—Angiopathy—Topiramate—epilepsy syndrome	1.85e-05	8.51e-05	CcSEcCtD
Riluzole—Pruritus—Lamotrigine—epilepsy syndrome	1.85e-05	8.5e-05	CcSEcCtD
Riluzole—Shock—Pregabalin—epilepsy syndrome	1.85e-05	8.5e-05	CcSEcCtD
Riluzole—Somnolence—Valproic Acid—epilepsy syndrome	1.85e-05	8.49e-05	CcSEcCtD
Riluzole—Immune system disorder—Topiramate—epilepsy syndrome	1.84e-05	8.47e-05	CcSEcCtD
Riluzole—Nervous system disorder—Pregabalin—epilepsy syndrome	1.84e-05	8.47e-05	CcSEcCtD
Riluzole—Cough—Gabapentin—epilepsy syndrome	1.84e-05	8.47e-05	CcSEcCtD
Riluzole—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.84e-05	8.46e-05	CcSEcCtD
Riluzole—Mediastinal disorder—Topiramate—epilepsy syndrome	1.84e-05	8.45e-05	CcSEcCtD
Riluzole—Tachycardia—Pregabalin—epilepsy syndrome	1.83e-05	8.43e-05	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.83e-05	0.000272	CbGpPWpGaD
Riluzole—Chills—Topiramate—epilepsy syndrome	1.83e-05	8.41e-05	CcSEcCtD
Riluzole—Dyspepsia—Valproic Acid—epilepsy syndrome	1.83e-05	8.41e-05	CcSEcCtD
Riluzole—Convulsion—Gabapentin—epilepsy syndrome	1.83e-05	8.41e-05	CcSEcCtD
Riluzole—Skin disorder—Pregabalin—epilepsy syndrome	1.82e-05	8.39e-05	CcSEcCtD
Riluzole—Hypertension—Gabapentin—epilepsy syndrome	1.82e-05	8.38e-05	CcSEcCtD
Riluzole—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.82e-05	8.35e-05	CcSEcCtD
Riluzole—Vomiting—Clonazepam—epilepsy syndrome	1.81e-05	8.34e-05	CcSEcCtD
Riluzole—Decreased appetite—Valproic Acid—epilepsy syndrome	1.81e-05	8.3e-05	CcSEcCtD
Riluzole—Alopecia—Topiramate—epilepsy syndrome	1.8e-05	8.29e-05	CcSEcCtD
Riluzole—Vomiting—Phenytoin—epilepsy syndrome	1.8e-05	8.28e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—STXBP1—epilepsy syndrome	1.8e-05	0.000268	CbGpPWpGaD
Riluzole—Rash—Clonazepam—epilepsy syndrome	1.8e-05	8.27e-05	CcSEcCtD
Riluzole—Dermatitis—Clonazepam—epilepsy syndrome	1.8e-05	8.26e-05	CcSEcCtD
Riluzole—Chest pain—Gabapentin—epilepsy syndrome	1.8e-05	8.26e-05	CcSEcCtD
Riluzole—Myalgia—Gabapentin—epilepsy syndrome	1.8e-05	8.26e-05	CcSEcCtD
Riluzole—Arthralgia—Gabapentin—epilepsy syndrome	1.8e-05	8.26e-05	CcSEcCtD
Riluzole—Nausea—Felbamate—epilepsy syndrome	1.8e-05	8.26e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.8e-05	0.000267	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.79e-05	8.25e-05	CcSEcCtD
Riluzole—Vomiting—Oxcarbazepine—epilepsy syndrome	1.79e-05	8.24e-05	CcSEcCtD
Riluzole—Fatigue—Valproic Acid—epilepsy syndrome	1.79e-05	8.24e-05	CcSEcCtD
Riluzole—Anxiety—Gabapentin—epilepsy syndrome	1.79e-05	8.23e-05	CcSEcCtD
Riluzole—Anorexia—Pregabalin—epilepsy syndrome	1.79e-05	8.23e-05	CcSEcCtD
Riluzole—Dizziness—Carbamazepine—epilepsy syndrome	1.79e-05	8.22e-05	CcSEcCtD
Riluzole—Diarrhoea—Lamotrigine—epilepsy syndrome	1.79e-05	8.22e-05	CcSEcCtD
Riluzole—Headache—Clonazepam—epilepsy syndrome	1.79e-05	8.22e-05	CcSEcCtD
Riluzole—SCN5A—Axon guidance—MMP9—epilepsy syndrome	1.79e-05	0.000266	CbGpPWpGaD
Riluzole—Rash—Phenytoin—epilepsy syndrome	1.79e-05	8.22e-05	CcSEcCtD
Riluzole—Mental disorder—Topiramate—epilepsy syndrome	1.79e-05	8.22e-05	CcSEcCtD
Riluzole—Dermatitis—Phenytoin—epilepsy syndrome	1.79e-05	8.21e-05	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.78e-05	8.2e-05	CcSEcCtD
Riluzole—Rash—Oxcarbazepine—epilepsy syndrome	1.78e-05	8.17e-05	CcSEcCtD
Riluzole—Constipation—Valproic Acid—epilepsy syndrome	1.78e-05	8.17e-05	CcSEcCtD
Riluzole—Pain—Valproic Acid—epilepsy syndrome	1.78e-05	8.17e-05	CcSEcCtD
Riluzole—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.78e-05	8.16e-05	CcSEcCtD
Riluzole—Headache—Phenytoin—epilepsy syndrome	1.78e-05	8.16e-05	CcSEcCtD
Riluzole—Malnutrition—Topiramate—epilepsy syndrome	1.78e-05	8.16e-05	CcSEcCtD
Riluzole—Discomfort—Gabapentin—epilepsy syndrome	1.78e-05	8.16e-05	CcSEcCtD
Riluzole—Headache—Oxcarbazepine—epilepsy syndrome	1.77e-05	8.12e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—QDPR—epilepsy syndrome	1.76e-05	0.000262	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CA4—epilepsy syndrome	1.76e-05	0.000262	CbGpPWpGaD
Riluzole—Nausea—Zonisamide—epilepsy syndrome	1.76e-05	8.08e-05	CcSEcCtD
Riluzole—Dry mouth—Gabapentin—epilepsy syndrome	1.76e-05	8.08e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—NT5E—epilepsy syndrome	1.76e-05	0.000261	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALAD—epilepsy syndrome	1.76e-05	0.000261	CbGpPWpGaD
Riluzole—Hypotension—Pregabalin—epilepsy syndrome	1.76e-05	8.07e-05	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—POMC—epilepsy syndrome	1.75e-05	0.000261	CbGpPWpGaD
Riluzole—Flatulence—Topiramate—epilepsy syndrome	1.75e-05	8.04e-05	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.75e-05	0.00026	CbGpPWpGaD
Riluzole—Tension—Topiramate—epilepsy syndrome	1.74e-05	8.01e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.74e-05	0.000259	CbGpPWpGaD
Riluzole—Dysgeusia—Topiramate—epilepsy syndrome	1.74e-05	7.99e-05	CcSEcCtD
Riluzole—Confusional state—Gabapentin—epilepsy syndrome	1.74e-05	7.98e-05	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.73e-05	0.000257	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.73e-05	0.000257	CbGpPWpGaD
Riluzole—Dizziness—Lamotrigine—epilepsy syndrome	1.73e-05	7.95e-05	CcSEcCtD
Riluzole—Nervousness—Topiramate—epilepsy syndrome	1.72e-05	7.93e-05	CcSEcCtD
Riluzole—Oedema—Gabapentin—epilepsy syndrome	1.72e-05	7.92e-05	CcSEcCtD
Riluzole—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.72e-05	7.92e-05	CcSEcCtD
Riluzole—Vomiting—Carbamazepine—epilepsy syndrome	1.72e-05	7.91e-05	CcSEcCtD
Riluzole—Back pain—Topiramate—epilepsy syndrome	1.72e-05	7.9e-05	CcSEcCtD
Riluzole—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.71e-05	7.87e-05	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.71e-05	7.87e-05	CcSEcCtD
Riluzole—Infection—Gabapentin—epilepsy syndrome	1.71e-05	7.87e-05	CcSEcCtD
Riluzole—Muscle spasms—Topiramate—epilepsy syndrome	1.71e-05	7.85e-05	CcSEcCtD
Riluzole—Rash—Carbamazepine—epilepsy syndrome	1.71e-05	7.84e-05	CcSEcCtD
Riluzole—Dermatitis—Carbamazepine—epilepsy syndrome	1.7e-05	7.84e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.7e-05	7.81e-05	CcSEcCtD
Riluzole—Insomnia—Pregabalin—epilepsy syndrome	1.7e-05	7.81e-05	CcSEcCtD
Riluzole—Nausea—Clonazepam—epilepsy syndrome	1.7e-05	7.79e-05	CcSEcCtD
Riluzole—Headache—Carbamazepine—epilepsy syndrome	1.7e-05	7.79e-05	CcSEcCtD
Riluzole—Shock—Gabapentin—epilepsy syndrome	1.69e-05	7.79e-05	CcSEcCtD
Riluzole—Nervous system disorder—Gabapentin—epilepsy syndrome	1.69e-05	7.77e-05	CcSEcCtD
Riluzole—Paraesthesia—Pregabalin—epilepsy syndrome	1.69e-05	7.75e-05	CcSEcCtD
Riluzole—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.69e-05	7.75e-05	CcSEcCtD
Riluzole—Nausea—Phenytoin—epilepsy syndrome	1.68e-05	7.74e-05	CcSEcCtD
Riluzole—Tachycardia—Gabapentin—epilepsy syndrome	1.68e-05	7.73e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ALDH7A1—epilepsy syndrome	1.68e-05	0.000249	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CACNA1A—epilepsy syndrome	1.68e-05	0.000249	CbGpPWpGaD
Riluzole—Dyspnoea—Pregabalin—epilepsy syndrome	1.68e-05	7.7e-05	CcSEcCtD
Riluzole—Nausea—Oxcarbazepine—epilepsy syndrome	1.68e-05	7.7e-05	CcSEcCtD
Riluzole—Skin disorder—Gabapentin—epilepsy syndrome	1.67e-05	7.69e-05	CcSEcCtD
Riluzole—Somnolence—Pregabalin—epilepsy syndrome	1.67e-05	7.68e-05	CcSEcCtD
Riluzole—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.67e-05	7.66e-05	CcSEcCtD
Riluzole—Tremor—Topiramate—epilepsy syndrome	1.66e-05	7.65e-05	CcSEcCtD
Riluzole—Vomiting—Lamotrigine—epilepsy syndrome	1.66e-05	7.64e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—COX3—epilepsy syndrome	1.65e-05	0.000246	CbGpPWpGaD
Riluzole—Urticaria—Valproic Acid—epilepsy syndrome	1.65e-05	7.59e-05	CcSEcCtD
Riluzole—Rash—Lamotrigine—epilepsy syndrome	1.65e-05	7.58e-05	CcSEcCtD
Riluzole—SCN5A—Axon guidance—SRC—epilepsy syndrome	1.65e-05	0.000245	CbGpPWpGaD
Riluzole—Ill-defined disorder—Topiramate—epilepsy syndrome	1.65e-05	7.57e-05	CcSEcCtD
Riluzole—Dermatitis—Lamotrigine—epilepsy syndrome	1.65e-05	7.57e-05	CcSEcCtD
Riluzole—Abdominal pain—Valproic Acid—epilepsy syndrome	1.64e-05	7.55e-05	CcSEcCtD
Riluzole—Body temperature increased—Valproic Acid—epilepsy syndrome	1.64e-05	7.55e-05	CcSEcCtD
Riluzole—Anorexia—Gabapentin—epilepsy syndrome	1.64e-05	7.55e-05	CcSEcCtD
Riluzole—Anaemia—Topiramate—epilepsy syndrome	1.64e-05	7.54e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ST3GAL3—epilepsy syndrome	1.64e-05	0.000244	CbGpPWpGaD
Riluzole—Headache—Lamotrigine—epilepsy syndrome	1.64e-05	7.53e-05	CcSEcCtD
Riluzole—Decreased appetite—Pregabalin—epilepsy syndrome	1.63e-05	7.51e-05	CcSEcCtD
Riluzole—Agitation—Topiramate—epilepsy syndrome	1.63e-05	7.5e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.62e-05	7.46e-05	CcSEcCtD
Riluzole—Fatigue—Pregabalin—epilepsy syndrome	1.62e-05	7.45e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	1.61e-05	0.00024	CbGpPWpGaD
Riluzole—Hypotension—Gabapentin—epilepsy syndrome	1.61e-05	7.4e-05	CcSEcCtD
Riluzole—Nausea—Carbamazepine—epilepsy syndrome	1.61e-05	7.39e-05	CcSEcCtD
Riluzole—Pain—Pregabalin—epilepsy syndrome	1.61e-05	7.38e-05	CcSEcCtD
Riluzole—Constipation—Pregabalin—epilepsy syndrome	1.61e-05	7.38e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ADSL—epilepsy syndrome	1.61e-05	0.000239	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	1.61e-05	0.000239	CbGpPWpGaD
Riluzole—Malaise—Topiramate—epilepsy syndrome	1.6e-05	7.36e-05	CcSEcCtD
Riluzole—Vertigo—Topiramate—epilepsy syndrome	1.6e-05	7.33e-05	CcSEcCtD
Riluzole—Syncope—Topiramate—epilepsy syndrome	1.59e-05	7.32e-05	CcSEcCtD
Riluzole—Leukopenia—Topiramate—epilepsy syndrome	1.59e-05	7.31e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—GLUL—epilepsy syndrome	1.58e-05	0.000234	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.57e-05	7.21e-05	CcSEcCtD
Riluzole—Palpitations—Topiramate—epilepsy syndrome	1.57e-05	7.21e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CACNA2D2—epilepsy syndrome	1.57e-05	0.000233	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—KCNB1—epilepsy syndrome	1.57e-05	0.000233	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC6A8—epilepsy syndrome	1.57e-05	0.000233	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PFKL—epilepsy syndrome	1.57e-05	0.000233	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLCO1A2—epilepsy syndrome	1.57e-05	0.000233	CbGpPWpGaD
Riluzole—Loss of consciousness—Topiramate—epilepsy syndrome	1.56e-05	7.17e-05	CcSEcCtD
Riluzole—Insomnia—Gabapentin—epilepsy syndrome	1.56e-05	7.16e-05	CcSEcCtD
Riluzole—Nausea—Lamotrigine—epilepsy syndrome	1.55e-05	7.14e-05	CcSEcCtD
Riluzole—Cough—Topiramate—epilepsy syndrome	1.55e-05	7.12e-05	CcSEcCtD
Riluzole—Feeling abnormal—Pregabalin—epilepsy syndrome	1.55e-05	7.12e-05	CcSEcCtD
Riluzole—Paraesthesia—Gabapentin—epilepsy syndrome	1.55e-05	7.11e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—CACNA1D—epilepsy syndrome	1.55e-05	0.00023	CbGpPWpGaD
Riluzole—Convulsion—Topiramate—epilepsy syndrome	1.54e-05	7.07e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.54e-05	7.06e-05	CcSEcCtD
Riluzole—Dyspnoea—Gabapentin—epilepsy syndrome	1.54e-05	7.06e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.53e-05	0.000228	CbGpPWpGaD
Riluzole—Hypertension—Topiramate—epilepsy syndrome	1.53e-05	7.05e-05	CcSEcCtD
Riluzole—Somnolence—Gabapentin—epilepsy syndrome	1.53e-05	7.04e-05	CcSEcCtD
Riluzole—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.53e-05	7.04e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.52e-05	0.000226	CbGpPWpGaD
Riluzole—Dyspepsia—Gabapentin—epilepsy syndrome	1.52e-05	6.97e-05	CcSEcCtD
Riluzole—Chest pain—Topiramate—epilepsy syndrome	1.51e-05	6.95e-05	CcSEcCtD
Riluzole—Arthralgia—Topiramate—epilepsy syndrome	1.51e-05	6.95e-05	CcSEcCtD
Riluzole—Myalgia—Topiramate—epilepsy syndrome	1.51e-05	6.95e-05	CcSEcCtD
Riluzole—Anxiety—Topiramate—epilepsy syndrome	1.51e-05	6.93e-05	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.5e-05	6.9e-05	CcSEcCtD
Riluzole—Decreased appetite—Gabapentin—epilepsy syndrome	1.5e-05	6.88e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—RELA—epilepsy syndrome	1.5e-05	0.000222	CbGpPWpGaD
Riluzole—Discomfort—Topiramate—epilepsy syndrome	1.49e-05	6.87e-05	CcSEcCtD
Riluzole—Urticaria—Pregabalin—epilepsy syndrome	1.49e-05	6.86e-05	CcSEcCtD
Riluzole—Asthenia—Valproic Acid—epilepsy syndrome	1.49e-05	6.85e-05	CcSEcCtD
Riluzole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.49e-05	6.84e-05	CcSEcCtD
Riluzole—Fatigue—Gabapentin—epilepsy syndrome	1.49e-05	6.83e-05	CcSEcCtD
Riluzole—Abdominal pain—Pregabalin—epilepsy syndrome	1.49e-05	6.83e-05	CcSEcCtD
Riluzole—Body temperature increased—Pregabalin—epilepsy syndrome	1.49e-05	6.83e-05	CcSEcCtD
Riluzole—Dry mouth—Topiramate—epilepsy syndrome	1.48e-05	6.8e-05	CcSEcCtD
Riluzole—Pain—Gabapentin—epilepsy syndrome	1.47e-05	6.77e-05	CcSEcCtD
Riluzole—Constipation—Gabapentin—epilepsy syndrome	1.47e-05	6.77e-05	CcSEcCtD
Riluzole—Pruritus—Valproic Acid—epilepsy syndrome	1.47e-05	6.76e-05	CcSEcCtD
Riluzole—Confusional state—Topiramate—epilepsy syndrome	1.46e-05	6.72e-05	CcSEcCtD
Riluzole—Oedema—Topiramate—epilepsy syndrome	1.45e-05	6.66e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—TXNRD1—epilepsy syndrome	1.45e-05	0.000215	CbGpPWpGaD
Riluzole—Infection—Topiramate—epilepsy syndrome	1.44e-05	6.62e-05	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.44e-05	0.000214	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—UPB1—epilepsy syndrome	1.43e-05	0.000213	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ATIC—epilepsy syndrome	1.43e-05	0.000213	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NEU1—epilepsy syndrome	1.43e-05	0.000213	CbGpPWpGaD
Riluzole—Shock—Topiramate—epilepsy syndrome	1.43e-05	6.55e-05	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.42e-05	0.000212	CbGpPWpGaD
Riluzole—Diarrhoea—Valproic Acid—epilepsy syndrome	1.42e-05	6.54e-05	CcSEcCtD
Riluzole—Nervous system disorder—Topiramate—epilepsy syndrome	1.42e-05	6.53e-05	CcSEcCtD
Riluzole—Feeling abnormal—Gabapentin—epilepsy syndrome	1.42e-05	6.53e-05	CcSEcCtD
Riluzole—Thrombocytopenia—Topiramate—epilepsy syndrome	1.42e-05	6.52e-05	CcSEcCtD
Riluzole—Tachycardia—Topiramate—epilepsy syndrome	1.41e-05	6.5e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.41e-05	6.48e-05	CcSEcCtD
Riluzole—Skin disorder—Topiramate—epilepsy syndrome	1.41e-05	6.47e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—AQP1—epilepsy syndrome	1.4e-05	0.000209	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.4e-05	0.000208	CbGpPWpGaD
Riluzole—Hyperhidrosis—Topiramate—epilepsy syndrome	1.4e-05	6.44e-05	CcSEcCtD
Riluzole—Hypersensitivity—Pregabalin—epilepsy syndrome	1.38e-05	6.36e-05	CcSEcCtD
Riluzole—Anorexia—Topiramate—epilepsy syndrome	1.38e-05	6.35e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—HSD17B4—epilepsy syndrome	1.38e-05	0.000205	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.38e-05	0.000205	CbGpPWpGaD
Riluzole—Dizziness—Valproic Acid—epilepsy syndrome	1.37e-05	6.32e-05	CcSEcCtD
Riluzole—Urticaria—Gabapentin—epilepsy syndrome	1.37e-05	6.29e-05	CcSEcCtD
Riluzole—Abdominal pain—Gabapentin—epilepsy syndrome	1.36e-05	6.26e-05	CcSEcCtD
Riluzole—Body temperature increased—Gabapentin—epilepsy syndrome	1.36e-05	6.26e-05	CcSEcCtD
Riluzole—Hypotension—Topiramate—epilepsy syndrome	1.35e-05	6.23e-05	CcSEcCtD
Riluzole—Asthenia—Pregabalin—epilepsy syndrome	1.35e-05	6.2e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GBE1—epilepsy syndrome	1.33e-05	0.000198	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPP1R3C—epilepsy syndrome	1.33e-05	0.000198	CbGpPWpGaD
Riluzole—Pruritus—Pregabalin—epilepsy syndrome	1.33e-05	6.11e-05	CcSEcCtD
Riluzole—Vomiting—Valproic Acid—epilepsy syndrome	1.32e-05	6.07e-05	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.32e-05	6.07e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.32e-05	0.000196	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.32e-05	0.000196	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.32e-05	0.000196	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.32e-05	0.000196	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.32e-05	0.000196	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.32e-05	0.000196	CbGpPWpGaD
Riluzole—Insomnia—Topiramate—epilepsy syndrome	1.31e-05	6.03e-05	CcSEcCtD
Riluzole—Rash—Valproic Acid—epilepsy syndrome	1.31e-05	6.02e-05	CcSEcCtD
Riluzole—Dermatitis—Valproic Acid—epilepsy syndrome	1.31e-05	6.02e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.3e-05	0.000194	CbGpPWpGaD
Riluzole—Headache—Valproic Acid—epilepsy syndrome	1.3e-05	5.98e-05	CcSEcCtD
Riluzole—Paraesthesia—Topiramate—epilepsy syndrome	1.3e-05	5.98e-05	CcSEcCtD
Riluzole—Dyspnoea—Topiramate—epilepsy syndrome	1.29e-05	5.94e-05	CcSEcCtD
Riluzole—Somnolence—Topiramate—epilepsy syndrome	1.29e-05	5.92e-05	CcSEcCtD
Riluzole—Diarrhoea—Pregabalin—epilepsy syndrome	1.29e-05	5.91e-05	CcSEcCtD
Riluzole—Dyspepsia—Topiramate—epilepsy syndrome	1.28e-05	5.86e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	1.28e-05	0.00019	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CHRM3—epilepsy syndrome	1.27e-05	0.000189	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	1.27e-05	0.000189	CbGpPWpGaD
Riluzole—Hypersensitivity—Gabapentin—epilepsy syndrome	1.27e-05	5.83e-05	CcSEcCtD
Riluzole—Decreased appetite—Topiramate—epilepsy syndrome	1.26e-05	5.79e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ASAH1—epilepsy syndrome	1.25e-05	0.000186	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.25e-05	5.75e-05	CcSEcCtD
Riluzole—Fatigue—Topiramate—epilepsy syndrome	1.25e-05	5.74e-05	CcSEcCtD
Riluzole—Dizziness—Pregabalin—epilepsy syndrome	1.24e-05	5.71e-05	CcSEcCtD
Riluzole—Pain—Topiramate—epilepsy syndrome	1.24e-05	5.7e-05	CcSEcCtD
Riluzole—Constipation—Topiramate—epilepsy syndrome	1.24e-05	5.7e-05	CcSEcCtD
Riluzole—Asthenia—Gabapentin—epilepsy syndrome	1.24e-05	5.68e-05	CcSEcCtD
Riluzole—Nausea—Valproic Acid—epilepsy syndrome	1.23e-05	5.67e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—STXBP1—epilepsy syndrome	1.22e-05	0.000181	CbGpPWpGaD
Riluzole—Pruritus—Gabapentin—epilepsy syndrome	1.22e-05	5.6e-05	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—AKT1—epilepsy syndrome	1.21e-05	0.00018	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.21e-05	0.000179	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.21e-05	0.000179	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.21e-05	0.000179	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.21e-05	0.000179	CbGpPWpGaD
Riluzole—Vomiting—Pregabalin—epilepsy syndrome	1.19e-05	5.49e-05	CcSEcCtD
Riluzole—Feeling abnormal—Topiramate—epilepsy syndrome	1.19e-05	5.49e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—NT5E—epilepsy syndrome	1.19e-05	0.000177	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALAD—epilepsy syndrome	1.19e-05	0.000177	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.19e-05	5.45e-05	CcSEcCtD
Riluzole—Rash—Pregabalin—epilepsy syndrome	1.18e-05	5.44e-05	CcSEcCtD
Riluzole—Dermatitis—Pregabalin—epilepsy syndrome	1.18e-05	5.44e-05	CcSEcCtD
Riluzole—Diarrhoea—Gabapentin—epilepsy syndrome	1.18e-05	5.42e-05	CcSEcCtD
Riluzole—Headache—Pregabalin—epilepsy syndrome	1.18e-05	5.41e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—SRC—epilepsy syndrome	1.18e-05	0.000175	CbGpPWpGaD
Riluzole—Urticaria—Topiramate—epilepsy syndrome	1.15e-05	5.29e-05	CcSEcCtD
Riluzole—Body temperature increased—Topiramate—epilepsy syndrome	1.15e-05	5.27e-05	CcSEcCtD
Riluzole—Abdominal pain—Topiramate—epilepsy syndrome	1.15e-05	5.27e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	1.15e-05	0.00017	CbGpPWpGaD
Riluzole—Dizziness—Gabapentin—epilepsy syndrome	1.14e-05	5.24e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	1.13e-05	0.000169	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	1.13e-05	0.000169	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.12e-05	0.000167	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.12e-05	0.000167	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.12e-05	0.000166	CbGpPWpGaD
Riluzole—Nausea—Pregabalin—epilepsy syndrome	1.12e-05	5.13e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	1.11e-05	0.000165	CbGpPWpGaD
Riluzole—Vomiting—Gabapentin—epilepsy syndrome	1.1e-05	5.03e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ADSL—epilepsy syndrome	1.09e-05	0.000162	CbGpPWpGaD
Riluzole—Rash—Gabapentin—epilepsy syndrome	1.09e-05	4.99e-05	CcSEcCtD
Riluzole—Dermatitis—Gabapentin—epilepsy syndrome	1.09e-05	4.99e-05	CcSEcCtD
Riluzole—Headache—Gabapentin—epilepsy syndrome	1.08e-05	4.96e-05	CcSEcCtD
Riluzole—Hypersensitivity—Topiramate—epilepsy syndrome	1.07e-05	4.91e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GLUL—epilepsy syndrome	1.07e-05	0.000158	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.06e-05	0.000157	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	1.05e-05	0.000156	CbGpPWpGaD
Riluzole—Asthenia—Topiramate—epilepsy syndrome	1.04e-05	4.78e-05	CcSEcCtD
Riluzole—Pruritus—Topiramate—epilepsy syndrome	1.03e-05	4.71e-05	CcSEcCtD
Riluzole—Nausea—Gabapentin—epilepsy syndrome	1.02e-05	4.7e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	1e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1e-05	0.000149	CbGpPWpGaD
Riluzole—Diarrhoea—Topiramate—epilepsy syndrome	9.92e-06	4.56e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—TNF—epilepsy syndrome	9.82e-06	0.000146	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	9.79e-06	0.000145	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.78e-06	0.000145	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.72e-06	0.000144	CbGpPWpGaD
Riluzole—Dizziness—Topiramate—epilepsy syndrome	9.58e-06	4.41e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—AQP1—epilepsy syndrome	9.5e-06	0.000141	CbGpPWpGaD
Riluzole—Vomiting—Topiramate—epilepsy syndrome	9.22e-06	4.24e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism—NEU1—epilepsy syndrome	9.15e-06	0.000136	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—UPB1—epilepsy syndrome	9.15e-06	0.000136	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ATIC—epilepsy syndrome	9.15e-06	0.000136	CbGpPWpGaD
Riluzole—Rash—Topiramate—epilepsy syndrome	9.14e-06	4.2e-05	CcSEcCtD
Riluzole—Dermatitis—Topiramate—epilepsy syndrome	9.13e-06	4.2e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.13e-06	0.000136	CbGpPWpGaD
Riluzole—Headache—Topiramate—epilepsy syndrome	9.08e-06	4.17e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	9.05e-06	0.000134	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	8.81e-06	0.000131	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.63e-06	0.000128	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	8.61e-06	0.000128	CbGpPWpGaD
Riluzole—Nausea—Topiramate—epilepsy syndrome	8.61e-06	3.96e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	8.6e-06	0.000128	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	8.6e-06	0.000128	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BCHE—epilepsy syndrome	8.58e-06	0.000127	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GBE1—epilepsy syndrome	8.51e-06	0.000126	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	8.51e-06	0.000126	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.31e-06	0.000124	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	8.18e-06	0.000122	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PLCB1—epilepsy syndrome	8.09e-06	0.00012	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TH—epilepsy syndrome	8.06e-06	0.00012	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	8e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.84e-06	0.000117	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	7.78e-06	0.000116	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NT5E—epilepsy syndrome	7.58e-06	0.000113	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALAD—epilepsy syndrome	7.58e-06	0.000113	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	7.31e-06	0.000109	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	7.23e-06	0.000107	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	7.23e-06	0.000107	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	7.08e-06	0.000105	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	7.01e-06	0.000104	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADSL—epilepsy syndrome	6.93e-06	0.000103	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	6.83e-06	0.000101	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GLUL—epilepsy syndrome	6.8e-06	0.000101	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	6.79e-06	0.000101	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.74e-06	0.0001	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMOX1—epilepsy syndrome	6.73e-06	0.0001	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	6.67e-06	9.92e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAT—epilepsy syndrome	6.64e-06	9.87e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCB1—epilepsy syndrome	6.46e-06	9.6e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	6.24e-06	9.28e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.14e-06	9.13e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	6.12e-06	9.1e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.06e-06	9e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GPX1—epilepsy syndrome	6.01e-06	8.92e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	5.83e-06	8.66e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.82e-06	8.65e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	5.81e-06	8.63e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	5.54e-06	8.23e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	5.48e-06	8.14e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	5.48e-06	8.14e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	5.48e-06	8.14e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TH—epilepsy syndrome	5.46e-06	8.11e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.37e-06	7.98e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AGT—epilepsy syndrome	5.27e-06	7.82e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOE—epilepsy syndrome	5.16e-06	7.67e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.1e-06	7.58e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5e-06	7.43e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	4.56e-06	6.77e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAT—epilepsy syndrome	4.5e-06	6.68e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.47e-06	6.64e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—POMC—epilepsy syndrome	4.43e-06	6.59e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	4.37e-06	6.5e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	4.35e-06	6.47e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.33e-06	6.43e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.3e-06	6.38e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	4.07e-06	6.04e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—epilepsy syndrome	4.04e-06	6e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.92e-06	5.82e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	3.91e-06	5.8e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.72e-06	5.52e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.7e-06	5.5e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AGT—epilepsy syndrome	3.56e-06	5.3e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—epilepsy syndrome	3.54e-06	5.25e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.53e-06	5.25e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.49e-06	5.19e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOE—epilepsy syndrome	3.49e-06	5.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TH—epilepsy syndrome	3.48e-06	5.17e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.43e-06	5.09e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—POMC—epilepsy syndrome	3e-06	4.46e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.91e-06	4.32e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.87e-06	4.26e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.79e-06	4.14e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—epilepsy syndrome	2.74e-06	4.06e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.59e-06	3.85e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	2.39e-06	3.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.27e-06	3.38e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.23e-06	3.31e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.91e-06	2.84e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.78e-06	2.64e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.74e-06	2.59e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	2.27e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.2e-06	1.79e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	7.67e-07	1.14e-05	CbGpPWpGaD
